Skip to main content
. 2019 Feb 4;9:1265. doi: 10.1038/s41598-018-37666-5

Figure 4.

Figure 4

Dose-dependent inhibition of tumor cell survival in the presence of CMLD011580. (ag) Tumor cells of different hematological origins [multiple myeloma (MM1S, JJN3), diffuse large B cell lymphoma (Pfeiffer, Toledo, SC-1), mantle cell lymphoma (Mino), acute myeloid leukemia (AML-2), Burkitt’s lymphoma (Namalwa, Ramos, Raji), T-cell lymphoma (Molt-3) and B-cell lymphoma (RL)] were incubated with the indicated concentrations of CMLD011580 for 48 hrs and cell viability assessed by CellTiter Glo. Results are expressed relative to vehicle controls and are the mean ± SEM of 3 biological replicates. (h) IC50 of (−)-CR-1-31-b and CMDL011580 towards the indicated cells lines. Results are expressed as mean ± SEM of 3 biological replicates.